In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: Consequences for HSVtk/GCV anticancer gene therapy

Gene Therapy

Volumn 5, Issue 9, 1998, Pages 1221-1226

  Cirenei, N ^a   Colombo, B M ^a,b   Mesnil, M ^c   Benedetti, S ^a   Yamasaki, H ^c   Finocchiaro, G ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b CNRS   (France)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Bystander effect; Connexin 43; Gene transfer; Gliomas

Indexed keywords

CONNEXIN 43; GANCICLOVIR; GAP JUNCTION PROTEIN; MEMBRANE PROTEIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL COMMUNICATION; CELL GROWTH; CONTROLLED STUDY; DRUG DIFFUSION; FEMALE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031693323     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300714     Document Type: Article

References (20)

1. Beyer EC, Paul DL, Goodenough DA. Connexin family of gap junction protein. J Mem Biol 1990; 116: 187-194.
2. Yamasaki H, Naus CC. Role of connexin genes in growth control. Carcinogenesis 1996; 17: 1199-1213.
3. Zhu D, Caveney S, Kidder GM, Naus CCG. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling and cell proliferation. Proc Natl Acad Sci USA 1991; 88: 1883-1887.
4. Mehta PM et al. Incorporation of the gene for a cell-cell channel protein into transformed cells leads to normalization of growth. J Mem Biol 1991; 124: 207-225.
5. Naus CCG, Bechberger JF, Caveney S, Wilson JX. Expression of gap-junction genes in astrocytes and C6 glioma cells. Neurosci Lett 1991; 126: 33-36.
6. Colombo BM et al. The 'bystander effect': association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 1995; 6: 763-772.
7. Chen S-C, Pelletier DB, Ao P, Boynton AL. Connexin 43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Diff 1995; 6: 681-690.
8. Li Bi W, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic co-operation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gene Ther 1993; 4: 725-731.
9. Mesnil M et al. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996, 93: 1831-1835.
10. Culver KW et al. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
11. Barba D, Hardin J, Jasodhara R, Gage FH. Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 1993; 79: 729-735.
12. Ram Z et al. Summary of results and conclusion of the gene therapy of malignant brain tumors: clinical study. J Neurosurg 1995; 82: 343A.
13. Freeman SM, Ramesh R, Marrogi AJ. Immune system in suicide gene therapy. Lancet 1997; 349: 2-3.
14. Benedetti S et al. Limited efficacy of the HSVtk/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the IL-4 gene. Hum Gene Ther 1997; 8: 1345-1353.
15. Mesnil M, Piccoli C, Yamasaki H. A tumor suppressor gene, C×26, also mediates the bystander effect in Hela cells. Cancer Res 1997; 57: 2929-2932.
16. Vrionis FD et al. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase gene is dependent on connexin expression and cell communication via gap junctions. Gene Therapy 1997; 4: 577-585.
17. Dilber MS et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res 1997; 57: 1523-1528.
18. Fishman GI et al. The human connexin gene family of gap junction proteins; distinct chromosomal locations but similar structures. Genomics 1991; 10: 250-256.
19. Mesnil M et al. Negative control of HeLa cells by connexin genes: connexin species specificity. Cancer Res 1995; 55: 629-639.
20. Miller AD et al. Use of retroviral vectors for gene transfer and expression. Meth Enzymol 1993; 217: 581-599.